Mirapex (pramipexole) for Parkinson's

    The FDA just approved Mirapex (pramipexole) for Parkinson's. It's the first new drug for Parkinson's since Eldepryl (selegiline) was approved almost ten years ago.

    Mirapex is a dopamine agonist...similar to Permax (pergolide) and Parlodel (bromocriptine).

    Mirapex works at least as well as bromocriptine...and might cause fewer serious side effects. That's because Mirapex ISN'T an ergot derivative like Permax and Parlodel.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote